RETINALGENIX HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS
Live / Applied — Suspended — suspension check completed, case still suspended (as of 08 Aug 2025)
What this means for you
Not registered yet, but its 20 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98324339
- Mark type
- Design + words
- Filed
- 20 Dec 2023
- Attorney of record
- Megan E. Spitz
Goods and services
- Class 044 — Medical, beauty and agricultural services: High-resolution medical retinal imaging services; Remote monitoring of medical data for medical diagnosis and treatment; DNA and RNA genetic pharmacogenetic mapping for medical diagnostic and treatment purposes; Medical testing for diagnostic or treatment purposes
Owner
- Retinalgenix Technologies Inc., Petaluma, CA, US
Prosecution history
- 08 Aug 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 07 Aug 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 06 Feb 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 06 Feb 2025 — LETTER OF SUSPENSION E-MAILED
- 06 Feb 2025 — SUSPENSION LETTER WRITTEN
- 03 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Sept 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 03 Sept 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 31 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 May 2024 — NON-FINAL ACTION E-MAILED
- 31 May 2024 — NON-FINAL ACTION WRITTEN
- 15 May 2024 — ASSIGNED TO EXAMINER
- 01 Apr 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED